Immunohistochemical markers for histopathological diagnosis and differentiation of acute cutaneous graft‐versus‐host disease. Issue 12 (5th July 2021)
- Record Type:
- Journal Article
- Title:
- Immunohistochemical markers for histopathological diagnosis and differentiation of acute cutaneous graft‐versus‐host disease. Issue 12 (5th July 2021)
- Main Title:
- Immunohistochemical markers for histopathological diagnosis and differentiation of acute cutaneous graft‐versus‐host disease
- Authors:
- Wegner, Joanna
Weidenthaler‐Barth, Beate
Engelbert, Julia
Knothe, Max
Braun, Claudia
Helbig, Doris
Sacher, Christopher
Kreft, Andreas
Wagner, Eva M.
Ziemer, Mirjana
Meyer, Ralf G.
von Stebut, Esther - Abstract:
- Abstract: Graft‐versus‐host disease (GvHD) is a major complication following stem‐cell or solid‐organ transplantation. Accurate diagnosis of cutaneous GvHD is challenging, given that drug eruptions and viral rashes may present with similar clinical/histological manifestations. Specific markers are not available. We performed the histological examination of biopsy samples from acute GvHD (aGvHD; n = 54), Stevens‐Johnson syndrome/toxic epidermal necrolysis (SJS/TEN; n = 27), maculopapular drug eruption (MDE; n = 26) and healthy controls ( n = 26). Samples of aGvHD showed a decrease in Langerhans cells (LC, p = 0.0001) and an increase in macrophages (MΦ, p = 0.0001) compared to healthy skin. Compared to SJS/TEN, MDE and healthy skin, aGvHD biopsies contained greater numbers of CD4 + and CD8 + T cells. The majority of CD4 + T‐helper cells were localized in the upper dermis, whereas cytotoxic CD8 + T cells were found in the epidermis. Increased numbers of CD56 + natural killer (NK) cells in the upper dermis of aGvHD skin ( p = 0.007) were not observed in controls or SJS/TEN and MDE. There were no differences in elafin staining between aGvHD and the latter two conditions. Acute GvHD appears to have a distinct inflammatory cell profile (T cells/NK cells) that may aid establishing in a more accurate diagnosis, especially when used to rule out differential diagnoses such as SJS/TEN or MDE.
- Is Part Of:
- Experimental dermatology. Volume 30:Issue 12(2021)
- Journal:
- Experimental dermatology
- Issue:
- Volume 30:Issue 12(2021)
- Issue Display:
- Volume 30, Issue 12 (2021)
- Year:
- 2021
- Volume:
- 30
- Issue:
- 12
- Issue Sort Value:
- 2021-0030-0012-0000
- Page Start:
- 1814
- Page End:
- 1819
- Publication Date:
- 2021-07-05
- Subjects:
- biomarker -- graft‐versus‐host disease -- immunohistochemistry -- maculopapular drug eruption -- Stevens‐Johnson syndrome/toxic epidermal necrolysis
Dermatology -- Periodicals
616.5 - Journal URLs:
- http://www.blackwellpublishing.com/journal.asp?ref=0906-6705&site=1 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1600-0625 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/exd.14416 ↗
- Languages:
- English
- ISSNs:
- 0906-6705
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3839.070000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 19693.xml